Literature DB >> 20061271

Unusual cause of ectopic secretion of adrenocorticotropic hormone: Cushing syndrome attributable to small cell prostate cancer.

Omalkhaire M Alshaikh1, Abdulraof A Al-Mahfouz, Hindi Al-Hindi, Ali Bin Mahfouz, Ali S Alzahrani.   

Abstract

OBJECTIVE: To report a rare cause of ectopic adrenocorticotropic hormone (ACTH) secretion leading to severe Cushing syndrome.
METHODS: We describe the clinical presentation and management of a case of Cushing syndrome attributable to ectopic ACTH secretion from small cell cancer of the prostate.
RESULTS: In a 70-year-old man with hypertension and diabetes, congestive heart failure developed. He was found to have severe hypokalemia (serum potassium, 1.7 mEq/L) and a huge pelvic mass on a computed tomographic scan performed because of a complaint of urinary retention. Transurethral biopsy of the prostate showed features of small cell prostate cancer. Hormonal evaluation revealed a high urine free cortisol excretion of 6,214.5 microg/d (reference range, 36 to 137), confirming the diagnosis of Cushing syndrome. A serum ACTH level was elevated at 316 ng/dL (reference range, 10 to 52). An overnight high-dose (8 mg orally) dexamethasone suppression test was positive (serum cortisol levels were 43.2 and 41 microg/dL before and after suppression, respectively), and magnetic resonance imaging of the pituitary gland disclosed no abnormalities. A prostate biopsy specimen showed small cell prostate cancer with positive staining for ACTH. The tumor was found to be unresectable, and the poor condition of the patient did not allow for bilateral adrenalectomy. He was treated with ketoconazole and metyrapone, which yielded good temporary control of his Cushing syndrome (24-hour urine free cortisol decreased to 55.2 microg/d). He received 1 cycle of chemotherapy (etoposide and cisplatin), but he died 6 months later as a result of sepsis.
CONCLUSION: Small cell prostate cancer is a rare subtype that can be associated with ectopic secretion of ACTH and severe Cushing syndrome. With this subtype of prostate cancer, Cushing syndrome should be considered and appropriately managed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20061271     DOI: 10.4158/EP09243.CR

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  6 in total

Review 1.  Small cell carcinoma of the prostate.

Authors:  Rosa Nadal; Michael Schweizer; Oleksandr N Kryvenko; Jonathan I Epstein; Mario A Eisenberger
Journal:  Nat Rev Urol       Date:  2014-02-18       Impact factor: 14.432

Review 2.  Severe Cushing's syndrome due to small cell prostate carcinoma: a case and review of literature.

Authors:  M S Elston; V B Crawford; M Swarbrick; M S Dray; M Head; J V Conaglen
Journal:  Endocr Connect       Date:  2017-06-05       Impact factor: 3.335

3.  Challenging Case of Ectopic ACTH Secretion from Prostate Adenocarcinoma.

Authors:  Wanling Zeng; Joan Khoo
Journal:  Case Rep Endocrinol       Date:  2022-03-31

4.  ECTOPIC ADRENOCORTICOTROPIC HORMONE SYNDROME DUE TO METASTATIC PROSTATE CANCER WITH NEUROENDOCRINE DIFFERENTIATION.

Authors:  Malini Soundarrajan; Henry Zelada; Jean Victoria Fischer; Peter Kopp
Journal:  AACE Clin Case Rep       Date:  2019-04-25

5.  Dual Paraneoplastic Endocrine Syndromes Heralding Onset of Extrapulmonary Small Cell Carcinoma: A Case Report and Narrative Review.

Authors:  Jill B Feffer; Natalia M Branis; Jeanine B Albu
Journal:  Front Endocrinol (Lausanne)       Date:  2018-04-18       Impact factor: 5.555

6.  Multiple hormone secretion may indicate worse prognosis in patients with ectopic Cushing's syndrome.

Authors:  Ieva Lase; Ieva Strele; Malin Grönberg; Gordana Kozlovacki; Staffan Welin; Eva Tiensuu Janson
Journal:  Hormones (Athens)       Date:  2020-01-16       Impact factor: 2.885

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.